SourceBio International (LON: SBI) has warned that it will be hit by the updated Covid-19-related travel requirements that mean that inbound fully vaccinated people will not need PCR tests on days two and eight. The effect on the diagnostics and storage company’s results is uncertain and the share price slumped 29.5p to 133p, but it is building up a cash pile and the operations are modestly rated.
Business will not disappear. Volumes had been growing and they will fall back. The average number of tests handled was 3,000 per day in the first half of 2021 and this rose to 7,000 per day in Ju...
